Announcement of the resolution of the second session of the 10th board of directors
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2018-001
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
10th Session 2 Board Resolution Announcement
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
1. Board Meeting
(I) The convening and convening of this board meeting complies with relevant laws, regulations and the company's "Articles of Association.
(II) 2018# On January 15, 29, the company issued the notice of the board meeting by fax, e-mail and personal service.
(III) 2018On January 19, the board meeting was held by means of a communication vote.
(IV) company has nine directors and nine directors participating in the voting.Deliberation of 2. Board Meeting
1
, "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical"
After deliberation and voting, the board of directors passed the proposal.The result of the vote was: 9
votes in favor, 0 votes against, and 0 abstentions.
For details, please refer to "Announcement on Foreign Investment of Subsidiary Jianfeng Pharmaceutical" (P.2018 -002)
Independent directors of the company expressed independent opinions on the investment matter, believing that the voting procedure of(1
) company's deliberation on "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical" conforms to the provisions of relevant laws, regulations and the company's Articles of Association, the decision-making process is legal and effective. The transaction follows the principles of fairness, openness and impartiality, and the pricing is fair and reasonable, and there is no harm to the interests of the company and shareholders.
(2) The parties to the transaction jointly commissioned Kunyuan Asset Appraisal Company Limited, which is qualified to practice securities, to evaluate the subject matter of the investment and issued the "Asset Appraisal Report" (Kunyuan Appraisal Report [2017] No. 1-37) . The appraisal agency is qualified to practice securities and futures, the appraisal agency's ability to meet the requirements of this appraisal work, and the appraisal process is independent.
(3) The relevant materials of the above-mentioned foreign investment items are fully prepared. We believe that the foreign investment items are in line with the company's development strategy. Jianfeng Pharmaceutical will use Shanghai Beika and its subsidiaries as platforms to establish R & D and production bases of raw materials and intermediates to further extend and improve the industrial chain of pharmaceutical business, which is conducive to increasing the scale of the company's pharmaceutical industry and improving the R & D capability of Jianfeng Pharmaceutical, it is conducive to enhancing the comprehensive strength of the peak pharmaceutical industry. agreed to the company's foreign investment matters.
Annex1
of the 3. Online Announcement, and the opinions of the 10th Independent Directors of the Company on the above related matters.
is hereby announcedZhejiang Jianfeng Group Co., Ltd. Board of Directors
January 19, 2018
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08